Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Northbaze Group | NBZ | Dec 27, 2024 | 0.17 | -6.18 |
Northern CapSek Ventures | CAPS | Dec 27, 2024 | 0.15 | -5.06 |
Northern CapSek Ventures PREF | CAPSPREF | Dec 27, 2024 | 0.64 | +4.07 |
Northgold | NG | Dec 27, 2024 | 0.60 | +2.54 |
Norva24 | NORVA | Dec 27, 2024 | 27.00 | +0.37 |
Nosa Plugs | NOSA | Dec 27, 2024 | 0.95 | +1.06 |
Nosium | NOSIUMB | Dec 27, 2024 | 6.20 | 0.00 |
Note | NOTE | Dec 27, 2024 | 149.50 | -0.13 |
Novotek B | NTEKB | Dec 27, 2024 | 72.20 | +0.56 |
Novus Group | NOVU | Dec 27, 2024 | 3.00 | 0.00 |
Nowonomics | NOWO | Dec 27, 2024 | 3.22 | +7.33 |
NP3 Fastigheter | NP3 | Dec 27, 2024 | 246.00 | +0.20 |
NP3 Fastigheter Pref | NP3PREF | Dec 27, 2024 | 29.90 | -0.33 |
NYAB | NYAB | Dec 27, 2024 | 5.00 | -0.60 |
Nyfosa | NYF | Dec 27, 2024 | 106.60 | +0.09 |
Obducat B | OBDUB | Dec 27, 2024 | 1.10 | -5.58 |
Observit | OBSE | Dec 27, 2024 | 0.46 | +0.22 |
ODI Pharma | ODI | Dec 27, 2024 | 2.12 | -25.35 |
Odinwell | ODIN | Dec 27, 2024 | 3.26 | +1.88 |
OEM International B | OEMB | Dec 27, 2024 | 110.80 | -0.36 |
Ogunsen B | OGUNB | Dec 27, 2024 | 31.15 | +1.30 |
OMX GES OMXS30 Ethical Price Index | OMXS30ETHIC | Dec 27, 2024 | 301.15 | 0.00 |
OMX NORDIC 40 | OMXN40 | Dec 27, 2024 | 2 513.08 | +1.45 |
OMX Oslo 20 GI | OMXO20GI | Dec 27, 2024 | 1 287.83 | +1.32 |
OMX Oslo 20 PI | OMXO20PI | Dec 27, 2024 | 709.78 | +1.32 |
OMX Stockholm 30 | OMXS30 | Dec 27, 2024 | 2 490.19 | +0.82 |
OMX Stockholm 30 GI | OMXS30GI | Dec 27, 2024 | 488.86 | +0.82 |
OMX Stockholm 60 Cap PI | OMXS60CAP | Dec 27, 2024 | 307.59 | +0.86 |
OMX Stockholm 60 PI | OMXS60PI | Dec 27, 2024 | 288.86 | +0.86 |
OMX Stockholm Automobiles & Parts PI | SX4010PI | Dec 27, 2024 | 1 219.26 | +1.72 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.